Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    0.00 (0.00%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Functionalised Masterbatch Used in Bolflex Sole

9 Feb 2021 07:00

RNS Number : 4333O
Haydale Graphene Industries PLC
09 February 2021
 

 

REACH

 

For immediate release

09 February 2021

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Haydale's Functionalised Nano-Enhanced Rubber Masterbatch Used in Bolflex Rubber Sole

 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that Bolflex has purchased 80 kg of its functionalised nano-enhanced rubber masterbatch for use in its premium soles range for shoe production. This follows Haydale recently increasing the elastomer capability of its functionalised nano-enhanced rubber masterbatch.

Haydales' products are incorporated into the styrene-butadiene rubber (SBR) compound offering increased tear strength, abrasion resistance, flex resistance, slip resistance and coefficient of friction - all essential properties for footwear.

The initial order of 80 kg enabled Bolflex, to prepare 3,000 pairs of functionalised nano-enhanced rubber soles and Bolflex are currently evaluating the performance of their nano-enhanced shoe sole product against their competitor's products. Initial results are demonstrating improvements against its footwear specific test standards. The Group expects to receive follow up orders during 2021.

According to Lucintel, the global footwear sole material market is expected to reach $21.0 billion by 2023. Bolflex is a market leading company, specialising in the production and supply of soles for the European footwear industry. It is now one of the largest manufacturers of the Iberian Peninsula and Europe with an existing capacity to manufacture around 20,000 pairs a day.

Pedro Saraiva, Head of Sales at Bolflex, said: "We have evaluated a number of nanomaterial products prior to purchasing Haydale's product and noted a dramatic step-change improvement as a direct result of the proprietary functionalisation process. This has shown improvements in the handling, dispersion and overall performance of the nanomaterials when mixed into rubber compounds."

Keith Broadbent, Haydale CEO, said: "We are really pleased to be working with Bolflex on this product and look forward to seeing the Haydale logo on the soles of shoes produced."

 

 

- Ends -

 

 

 

 

For further information:

Haydale Graphene Industries plc

 

Keith Broadbent, CEO

Tel: +44 (0) 1269 842 946

Gemma Smith, Global Head of Marketing

 

 

Arden Partners plc (Nominated Adviser & Broker)

 

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness through its state-of-the-art functionalisation. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene 

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGGZVLLGMZG
Date   Source Headline
28th Feb 202311:38 amRNSHaydale and GEIC Proud to Partner for a Sixth Year
21st Feb 20237:00 amRNSRega Turns to Graphene to Improve Sound Quality
14th Feb 20237:00 amRNSInnovate UK Grant to Image 2D Materials Awarded
7th Feb 20237:00 amRNSHaydale Paddles Forward with Norse Kayaks
30th Jan 20237:00 amRNSNotice of Interim Results
26th Jan 20237:00 amRNSCeramycGuard™ on Trial with United Utilities
20th Dec 20227:00 amRNSGraphene-Enhanced Prepreg Extends Tool Life
1st Dec 20227:00 amRNSFinalist for Collaborate to Innovate Awards
30th Nov 20229:22 amRNSGrant of Warrants
29th Nov 20221:55 pmRNSResult of AGM
15th Nov 20227:00 amRNSGrant of share options and PDMR dealings
1st Nov 20227:00 amRNSDirectorate Change and Posting of Annual Report
6th Oct 20227:00 amRNSFinal Results
20th Sep 20229:49 amRNSHolding(s) in Company
16th Sep 20227:00 amRNSDirector/PDMR Shareholding
15th Sep 20221:35 pmRNSDirector/PDMR Shareholding
13th Sep 20221:30 pmRNSBlock Admission Application
13th Sep 202210:30 amRNSResult of Open Offer
12th Sep 20221:27 pmRNSResult of General Meeting
7th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHaydale Has Food Packaging All Zipped Up
24th Aug 202210:17 amRNSResult of Fundraising
24th Aug 20229:00 amRNSPrice Monitoring Extension
23rd Aug 20224:37 pmRNSProposed Placing, Subscription and Open Offer
19th Aug 20224:41 pmRNSSecond Price Monitoring Extn
19th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20224:41 pmRNSSecond Price Monitoring Extn
8th Aug 20224:36 pmRNSPrice Monitoring Extension
25th Jul 202210:25 amRNSHolding(s) in Company
19th Jul 20227:00 amRNSPost Period End Trading Update
8th Jul 20227:00 amRNSHaydale & Vittoria partner for innovation & supply
7th Jun 20227:00 amRNSTrading Update
30th May 20224:51 pmRNSChange of Auditor
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
12th May 20222:06 pmRNSSecond Price Monitoring Extn
12th May 20222:00 pmRNSPrice Monitoring Extension
19th Apr 20227:00 amRNSHaydale Wins Awards for its Materials Technology
11th Apr 20227:00 amRNSAward of Grant to Develop Smart Composite Tooling
21st Mar 20227:00 amRNSNext Phase with Viritech
9th Mar 20227:00 amRNSSales Representation Agreement Signed
1st Mar 20225:26 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSRaising the Bar in Plastic Food Packaging
23rd Feb 20227:00 amRNSInterim Results
17th Feb 20227:00 amRNSContract to Develop Graphene Ink-Based Heaters
27th Jan 20227:00 amRNSHaydale Awarded Supply Agreement
21st Jan 20227:00 amRNSGrant of share options and PDMR dealings
12th Jan 20227:00 amRNSFunding to Develop Anti-Counterfeiting Technology

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.